Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EZH2 inhibitor combination therapies

EZH2 inhibitor combination therapies

US Patent 11529344 · Granted Dec 20, 2022

Estimated economic value: $1,984,317,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combined sub-iliopsoas and subpectineal blocks—for hip surgery2025
Benzisoxazole sulfonamide derivatives2025
Benzisoxazole sulfonamide derivatives2022
Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body2021
Cycloalkyl-linked diheterocycle derivatives2020
Substituted dihydroisoquinolinone compounds2020
Aryl and heteroaryl fused lactams2019
Cycloalkyl-linked diheterocycle derivatives2018
Substituted dihydroisoquinolinone compounds2016
Aryl and heteroaryl fused lactams2015
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors2014
Aminoheteroaryl compounds as protein kinase inhibitors2012